🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Exciting #STRIDE trial results on #semaglutide in #PAD & type 2 #DM, presented by Marc Bonaca MD MPH at #ACC25! CPC Clinical Research CU Cardiology The Lancet American College of Cardiology

Dr. Sivan Naveh's Case Presentation: A 35 Year Old With Type B Dissection - is the last ride of the day for CPC! 🎢📂🎢

Now showing at the Main Tent - Dr. Marc Bonaca is a panelist in the Featured Clinical Research IV panel! 🎪📋🎪

Grab a snack and catch - Highlighted Original Research: Vascular Diseases and the Year in Review - featuring Dr. Marc Bonaca! 🍿🥜🍿

No time for clowning around this morning! You'll definitely want to make your way to S403A to hear Dr. Shea Hogan's thoughts on this panel! 🤡⏳🤡

Juggling multiple presentations? We've got the one for you! Dr. Josephine Harrington presents - The Obesity Paradox in HF: Real or Illusory? - 🤹‍♀️📢🤹‍♀️

The final act for CPC at ACC 2025 is Dr. Byung Gyu Kim's poster presentation. Thank you for coming along for the ride! 🎡🔍🎡

🚨🚶CPC Announces Semaglutide Significantly Improves Walking Distance, Symptoms and Quality of Life for People with PAD and Diabetes🚶🚨 accessnewswire.com/newsroom/en/he…

Check out this informative interview with Dr. Marc Bonaca highlighting how STRIDE data could provide insight into peripheral artery disease and type 2 diabetes treatment options! ajmc.com/view/semagluti…

What an eventful and exciting ACC 2025! Find out more about the groundbreaking science we presented at ACC 2025 (such as the STRIDE primary results) at the link below! cpcclinicalresearch.org/academic-activ…

Great to see some CPC faces here! Mario Enrico Canonico and Shea Hogan 👋

Thrilled to join #EASCongress2025 to present data on bempedoic acid in patients with PAD! CPC Clinical Research CU Department of Medicine Marc Bonaca MD MPH EAS Congress European Atherosclerosis Society

Endpoint specificity and cause of death in CV trials: our experience from the MARINER trial CPC Clinical Research Marc Bonaca MD MPH JACC Journals #JACCAdvances sciencedirect.com/science/articl…

Current evidence and future perspectives in HFpEF therapy. #HREV Josephine Harrington, MD Caio de Assis Moura Tavares Andrew P. Ambrosy, MD, MPH orlyvardeny Andrew J Sauer MD Marc Bonaca MD MPH CPC Clinical Research link.springer.com/article/10.100…

🔥Controversy in Vascular Care! In this clip from our recent Data Deep Dive, Dr. Marc Bonaca shares new STRIDE-PAD findings, leading to a spirited conversation on semaglutide, real-world limitations, and the complexity of treatment decisions. Watch here: youtube.com/watch?v=GE6fNR…

#CONFIDENCE results: now explore HF #CONFIRMATION-HF, we enrolled 12th patient Saint Luke's Mid America Heart Institute today! Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients with Heart Failure (CONFIRMATION-HF) | ClinicalTrials.gov

Excited for Improving Cardiovascular Outcomes: The Next Era of Prevention - in Denver, June 12–13! Great event on CV prevention! National Jewish Health CPC Clinical Research Andrew Freeman, MD Marc Bonaca MD MPH nationaljewish.org/ImprovingCVout…

Heart disease doesn't wait, so why should care? 💪❤️ Join us at #SCCT2025 for a dynamic, case-based session that challenges the status quo and explores how Cleerly is reimagining #cardiovascularcare with advanced, plaque-based imaging. #YesCCT #Cardiology

The #MOONRAKER program is exploring finerenone across different HF settings, following FINEARTS-HF. CPC Clinical Research

Check out this exciting recent publication from the CPC team! 📱📈📱 pubmed.ncbi.nlm.nih.gov/40673521/